India Exchange Filings

Gland Pharma International Appoints Chief Investment Officer

Gland Pharma Ltd appoints Xiao Le as Chief Investment Officer of its wholly owned subsidiary, effective November 9, 2026

  • Xiao Le will explore investment opportunities and strengthen M&A capabilities across the US, China, Singapore and other markets.
  • He will report to the CEO of Gland Pharma International Pte. Ltd.
  • He brings more than 15 years of investment and asset-management experience across healthcare.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.